BioWorld Science

RSS

Acasti initiates TRILOGY trials of CaPre in patients with severe hypertriglyceridemia

Feb. 1, 2018

Cara Therapeutics begins pivotal phase III study of Korsuva in CKD-associated pruritus

Feb. 1, 2018

Oncolix sponsoring evaluation of Prolanta for other gynecological cancers

Feb. 1, 2018

FDA gives Protalix Biotherapeutics' PRX-102 fast track designation

Feb. 1, 2018

Sage Therapeutics' SAGE-217 improves sleep efficiency and sleep time in model of insomnia

Feb. 1, 2018

Preclinical data presented for adipoRon in cholangiocarcinoma

Feb. 1, 2018

Dermira begins phase IIb study of lebrikizumab in moderate to severe atopic dermatitis

Feb. 1, 2018

First patient treated in phase III study of BeiGene's tislelizumab

Feb. 1, 2018

Sumitomo Dainippon Pharma highlights progress of third quarter of fiscal 2017

Feb. 1, 2018

Armis Biopharma's Ximycin designated as QIDP by FDA

Feb. 1, 2018